Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration
Cell Chemical Biology · 2025-01 · 32 (1) · 25-45
DOI: 10.1016/j.chembiol.2024.08.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Chemical Biology, 2025-01. Verfasst von Lara Kern und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Gastrointestinal Microbiome. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 203 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Ministry of Science and Technology, Israel, Wellcome Trust.
Abstract (Originalsprache)
Recent developments in microbiome research suggest that the gut microbiome may remotely modulate central and peripheral neuronal processes, ranging from early brain development to age-related changes. Dysbiotic microbiome configurations have been increasingly associated with neurological disorders, such as neurodegeneration, but causal understanding of these associations remains limited. Most mechanisms explaining how the microbiome may induce such remote neuronal effects involve microbially modulated metabolites that influx into the 'sterile' host. Some metabolites are able to cross the blood-brain barrier (BBB) to reach the central nervous system, where they can impact a variety of cells and processes. Alternatively, metabolites may directly signal to peripheral nerves to act as neurotransmitters or exert modulatory functions, or impact immune responses, which, in turn, modulate neuronal function and associated disease propensity. Herein, we review the current knowledge highlighting microbiome-modulated metabolite impacts on neuronal disease, while discussing unknowns, controversies and prospects impacting this rapidly evolving research field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Microbiome & Cancer Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel; Microbiome & Cancer Division, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: eran.elinav@weizmann.ac.il.
Förderung
- Deutsche Forschungsgemeinschaft
- Ministry of Science and Technology, Israel
- Wellcome Trust
- Mark Foundation For Cancer Research
- Leona M. and Harry B. Helmsley Charitable Trust
- Ministry of Health, State of Israel
- Garvan Institute of Medical Research
- Howard Hughes Medical Institute
Zitieren
APA
Kern, L., Mastandrea, I., Melekhova, A., & Elinav, E. (2025). Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration. Cell Chemical Biology, 32(1), 25-45. https://doi.org/10.1016/j.chembiol.2024.08.014
Vancouver
Kern L, Mastandrea I, Melekhova A, Elinav E. Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration. Cell Chemical Biology. 2025;32(1):25-45. doi:10.1016/j.chembiol.2024.08.014
BibTeX
@article{Kern2025,
author = {Kern, Lara and Mastandrea, Ignacio and Melekhova, Anna and Elinav, Eran},
title = {Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration},
journal = {Cell Chemical Biology},
year = {2025},
volume = {32},
number = {1},
pages = {25--45},
doi = {10.1016/j.chembiol.2024.08.014}
}
EUVIMED